ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Commission has authorised Vocabria (cabotegravir ...

Nigeria’s leaders have long prioritised vanity projects over the welfare of their citizens. In 2023 alone, the government ...